Viewing Study NCT01813461


Ignite Creation Date: 2025-12-24 @ 12:08 PM
Ignite Modification Date: 2026-01-12 @ 9:17 AM
Study NCT ID: NCT01813461
Status: COMPLETED
Last Update Posted: 2013-03-19
First Post: 2013-03-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate the Pharmacokinetics of 14C-labeled Isavuconazole Following a Single Oral Dose of 14C-labeled Prodrug Isavuconazonium Sulfate (BAL8557) in Healthy Male Subjects
Sponsor: Astellas Pharma Global Development, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 9766-CL-0016
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View